Success of immunomodulators in MS shifts discovery focus to neuroprotection

Nat Rev Drug Discov. 2011 Dec 1;10(12):885-7. doi: 10.1038/nrd3610.
No abstract available

Publication types

  • News

MeSH terms

  • Clinical Trials, Phase II as Topic / trends
  • Clinical Trials, Phase III as Topic / trends
  • Drug Discovery / trends*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Multiple Sclerosis, Relapsing-Remitting / pathology
  • Multiple Sclerosis, Relapsing-Remitting / prevention & control*
  • Neuroprotective Agents / therapeutic use*

Substances

  • Immunologic Factors
  • Neuroprotective Agents